Since the expression DCX and UCHL-1 may increase the ability of BPDCN tumor cells to disseminate to distant organs, globally worsening patient outcome, both genes, as already suggested for NLGN4X and EDN3, may be regarded as possible therapeutic targets to arrest BPDCN dissemination. Here, EDN3 is linked to neoplasm.